Authors:
Korkolopoulou, P
Apostolidou, E
Pavlopoulos, PM
Kavantzas, N
Vyniou, N
Thymara, I
Terpos, E
Patsouris, E
Yataganas, X
Davaris, P
Citation: P. Korkolopoulou et al., Prognostic evaluation of the microvascular network in myelodysplastic syndromes, LEUKEMIA, 15(9), 2001, pp. 1369-1376
Authors:
Viniou, N
Terpos, E
Rombos, J
Vaiopoulos, G
Nodaros, K
Stamatopoulos, K
Meletis, J
Yataganas, X
Citation: N. Viniou et al., Acute myeloid leukemia in a patient with ataxia-telangiectasia: a case report and review of the literature, LEUKEMIA, 15(10), 2001, pp. 1668-1670
Authors:
Terpos, E
Palermos, J
Viniou, N
Vaiopoulos, G
Meletis, J
Yataganas, X
Citation: E. Terpos et al., Pamidronate increases markers of bone formation in patients with multiple myeloma in plateau phase under interferon-alpha treatment, CALCIF TIS, 68(5), 2001, pp. 285-290
Authors:
Stavroyianni, N
Viniou, N
Vaiopoulos, G
Yataganas, X
Citation: N. Stavroyianni et al., Autoimmune hemolytic anemia during alpha-interferon treatment in a patientwith chronic myelogenous lenkemia, LEUK RES, 25(12), 2001, pp. 1097-1098
Authors:
Meletis, J
Terpos, E
Samarkos, M
Meletis, C
Konstantopoulos, K
Komninaka, V
Apostolidou, E
Benopoulou, O
Korovesis, K
Mavrogianni, D
Variami, E
Yataganas, X
Loukopoulos, D
Citation: J. Meletis et al., Detection of CD55 and/or CD59 deficient red cell populations in patients with aplastic anaemia, myelodysplastic syndromes and myeloproliferative disorders, HAEMATOLOGI, 31(1), 2001, pp. 7-16
Authors:
Kollia, P
Stavroyianni, N
Stamatopoulos, K
Zoi, K
Viniou, N
Mantzourani, M
Noguchi, CT
Paterakis, G
Abazis, D
Pangalos, C
Loukopoulos, D
Yataganas, X
Citation: P. Kollia et al., Molecular analysis of transferrin receptor mRNA expression in acute myeloid leukaemia, BR J HAEM, 115(1), 2001, pp. 19-24
Authors:
Plata, E
Choremi-Papadopoulou, H
Viglis, V
Yataganas, X
Citation: E. Plata et al., Flow-cytometric detection of minimal residual disease with atypical antigen combinations in patients with de novo acute myeloid leukemia, ANN HEMATOL, 79(10), 2000, pp. 543-546
Authors:
Terpos, E
Palermos, J
Tsionos, K
Anargyrou, K
Viniou, N
Papassavas, P
Meletis, J
Yataganas, X
Citation: E. Terpos et al., Effect of pamidronate administration on markers of bone turnover and disease activity in multiple myeloma, EUR J HAEMA, 65(5), 2000, pp. 331-336
Authors:
Kosmas, C
Stamatopoulos, K
Stavroyianni, N
Zoi, K
Belessi, C
Viniou, N
Kollia, P
Yataganas, X
Citation: C. Kosmas et al., Origin and diversification of the clonogenic cell in multiple myeloma: lessons from the immunoglobulin repertoire, LEUKEMIA, 14(10), 2000, pp. 1718-1726
Authors:
Akel, S
Kolialexi, A
Mavrou, A
Metaxotou, C
Loukopoulos, D
Yataganas, X
Citation: S. Akel et al., Evaluation at single cell level of residual Philadelphia negative hemopoietic stem cells in chronic phase CML patients, CANC GENET, 122(2), 2000, pp. 93-100
Authors:
Stavroyianni, N
Yataganas, X
Abazis, D
Pangalos, C
Meletis, J
Citation: N. Stavroyianni et al., Acute promyelocytic leukemia relapsing into FAB-M2 acute myeloid leukemia with trisomy 8, CANC GENET, 117(1), 2000, pp. 82-83
Authors:
Stavroyianni, N
Kalmantis, T
Yataganas, X
Citation: N. Stavroyianni et al., Simultaneous PML/RAR alpha and AML 1/ETO gene rearrangements in a patient with acute myeloid leukemia, LEUKEMIA, 13(8), 1999, pp. 1294-1295